Development of a linear dual column HPLC–MS/MS method and clinical genetic evaluation for tramadol and its phase I and II metabolites in oral fluid

논문상세정보
    • 저자 유혜림 홍성국 정철호 배정우 이수연
    • 제어번호 106038489
    • 학술지명 Archives of Pharmacal Research
    • 권호사항 Vol. 41 No. 3 [ 2018 ]
    • 발행처 대한약학회
    • 발행처 URL http://www.psk.or.kr
    • 자료유형 학술저널
    • 수록면 288-298 ( 11쪽)
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 소장기관 부산대학교 중앙도서관 숙명여자대학교 중앙도서관 영남대학교 중앙도서관 영남대학교 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관
    • 판매처
    유사주제 논문( 0)

' Development of a linear dual column HPLC–MS/MS method and clinical genetic evaluation for tramadol and its phase I and II metabolites in oral fluid' 의 참고문헌

  • Validated determination method of tramadol and its desmethylates in human plasma using an isocratic LC-MS/MS and its clinical application to patients with cancer pain or non-cancer pain
    Tanaka H [2016]
  • Tramadol, pharmacology, side effects, and serotonin syndrome: a review
    Beakley BD [2015]
  • Tramadol hydrochloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems
    Vazzana M [2015]
  • Tramadol deaths in Northern Ireland: a review of cases from 1996 to 2012
    Randall C [2014]
  • The potential role of oral fluid in antidoping testing
    Anizan S [2014]
  • The pharmacogenetics of tramadol
    Lassen D [2015]
  • Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS
  • Stereospecific high-performance liquid chromatographic analysis of tramadol and its O-demethylated (M1) and N, O-demethylated (M5) metabolites in human plasma
    Mehvar R [2007]
  • Simultaneous stereoselective analysis of tramadol and its primary phase I metabolites in plasma by liquid chromatography. Application to a pharmacokinetic study in humans
  • Saliva testing for drugs of abuse
    Cone EJ [1993]
  • Saliva in studies of epidemiology of human disease: the UK Biobank project
    Galloway JW [2016]
  • Review: the physiology of saliva and transfer of drugs into saliva
    Aps JK [2005]
  • Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis
    Huestis MA [2004]
  • Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers
    Li Q [2010]
  • Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection
    George R [2016]
  • Polymorphism of human cytochrome P450 2D6 and its clinical significance: part I
    Zhou SF [2009]
  • Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration
    Kim I [2002]
  • Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype
  • Pharmacokinetic properties of tramadol sustained release capsules. 3rd communication: investigation of relative bioavailability under steady state conditions
    Raber M [1999]
  • PharmGKB summary: tramadol pathway
    Gong L [2014]
  • PCR-based genotyping for duplicated and deleted CYP2D6 genes
    Johansson I [1996]
  • Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration
    Lee D [2013]
  • Oral fluid for the detection of drugs of abuse using immunoassay and LC-MS/MS
    Moore C [2013]
  • Opioid concentrations in oral fluid and plasma in cancer patients with pain
    Heiskanen T [2015]
  • Method validation;Applications of LC-MS in Toxicology
    Peters FT [2006]
  • Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of risperidone in healthy subjects with CYP2D6*10/*10
    Yoo HD [2011]
  • High-performance liquid chromatographic determination of tramadol and its O-desmethylated metabolite in blood plasma. Application to a bioequivalence study in humans
    Nobilis M [2002]
  • HPLC-MS for the determination of sildenafil citrate (Viagra) in biological fluids. Application to the salivary excretion of sildenafil after oral intake
    Tracqui A [2003]
  • Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity
  • Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes
    Lundqvist E [1999]
  • First report on the pharmacokinetics of tramadol and O-desmethyltramadol in exhaled breath compared to plasma and oral fluid after a single oral dose
    Meyer MR [2015]
  • Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites
    변지영 [2015]
  • Development of K-BE test, a computer program for the analysis of bioequivalence
    Lee YJ [1998]
  • Determination of tramadol and O-desmethyltramadol in human plasma by high-performance liquid chromatography with mass spectrometry detection
    Vlase L [2008]
  • Detection of inflammatory biomarkers in saliva and urine: potential in diagnosis, prevention, and treatment for chronic diseases
    Prasad S [2016]
  • Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and non-CYP2D6 pathways on biotransformation
  • Clinical pharmacology of tramadol
    Grond S [2004]
  • Appendix B, To the GTFCh Guidelines for quality assurance in forensic-toxicological analyses, requirements for the validation of analytical methods
    Peters FT [2009]
  • Alternative sampling strategies for the assessment of alcohol intake of living persons
    Kummer N [2016]